The molecular biology of thrombotic microangiopathy
Open Access
- 1 July 2006
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 70 (1), 16-23
- https://doi.org/10.1038/sj.ki.5001535
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Current Concepts in Thrombotic Thrombocytopenic PurpuraAnnual Review of Medicine, 2006
- Hemolytic uremic syndrome–associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimersBlood, 2005
- Enzymatically Active ADAMTS13 Variants Are Not Inhibited by Anti-ADAMTS13 AutoantibodiesJournal of Biological Chemistry, 2005
- Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient miceJournal of Clinical Investigation, 2005
- ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseasesBlood, 2005
- The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohortsJournal of Medical Genetics, 2005
- ADAMTS13 gene mutation in congenital thrombotic thrombocytopenic purpura with previously reported normal VWF cleaving protease activityBlood, 2003
- ADAMTS 13 genotype and vWF protease activity in an Italian family with TTPThrombosis and Haemostasis, 2003
- ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditionsBlood, 2002
- H deficiency in two brothers with atypical dense intramembranous deposit diseaseKidney International, 1986